Exacerbation of Chronic Spontaneous Urticaria Following Coronavirus Disease 2019 (COVID-19) Vaccination in Omalizumab-Treated Patients

BACKGROUND: The rapid development and rollout of vaccines against coronavirus disease 2019 (COVID-19) has led to more than half of the world's population being vaccinated to date. Real-world data have reported various adverse cutaneous reactions, including delayed-onset urticaria, which was hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Hyang, Shin, Eunyong, Kim, Hyun-Kyoung, Song, Woo-Jung, Kwon, Hyouk-Soo, Kim, Tae-Bum, Cho, You Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176887/
https://www.ncbi.nlm.nih.gov/pubmed/37182571
http://dx.doi.org/10.1016/j.jaip.2023.04.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176887/
https://www.ncbi.nlm.nih.gov/pubmed/37182571
http://dx.doi.org/10.1016/j.jaip.2023.04.050

Ejemplares similares